BDP9066
BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer.
Product Specifications
CAS Number
2226507-04-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
348.44
Molecular Formula
C20H24N6
Notes
Research use only, not for human use.
Receptor
ROCK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15342895 1 Vial
Lentiviral human SLC31A2 shRNA (UAS) - Lentiviral human SLC31A2 shRNA (UAS, iRFP) plasmid
Ask
View Details